Remove 2018 Remove Generic Medicine Remove Vaccines
article thumbnail

Novartis looking into future of its Sandoz’ generics business

pharmaphorum

Novartis revealed today that it may consider divesting its generic medicines subsidiary Sandoz – amongst other options – which would further narrow its focus to innovative medicines.

article thumbnail

The critical role of the generics sector during the pandemic

pharmaphorum

“Now more than ever, it is our responsibility as a sector to ensure affordable access to healthcare and enable the future longevity of medicine development and supply.”. The generics medicines sector can, too, play a substantial part in discovering new areas for licensed products to be used in. Delivery of essential medicines.